BTG Pactual Global Asset Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

BTG Pactual Global Asset Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-150,000	Closed	-$2.54M	–	240
2014 Q4	$2.54M	Buy	+150,000	New	+$2.11M	0.22%	72

BTG Pactual Global Asset Management's AVNR Position: Q1 2015 in Review

BTG Pactual Global Asset Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 150,000 shares — an estimated $2.54M sold.

BTG Pactual Global Asset Management first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $2.54M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

BTG Pactual Global Asset Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
BTG Pactual Global Asset Management sold 150,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $2.54M.
BTG Pactual Global Asset Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
BTG Pactual Global Asset Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.54M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on BTG Pactual Global Asset Management's 13F filing for Q1 2015, filed 14 May 2015.